Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2013

May 13, 2013

30198_dirs_2013-05-13_6853b7d6-b056-4dc5-853a-3ec3167f2ef3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2013-05-09

Reporting Person: DOUBLEDAY RICHARD (SVP, Worldwide Sales)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-05-09 Common Stock S 692 $19.5536 Disposed 92553 Direct
2013-05-09 Common Stock S 580 $19.5588 Disposed 91973 Direct

Footnotes

F1: Included in this number are 75,667 unvested restricted stock units, 50,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016, 17,083 of which were granted on March 8, 2012 and shall vest through March 8, 2015, and 8,584 of which were granted on March 8, 2011 and shall vest through March 8, 2014.